Literature DB >> 27440815

Detection of (1→3)-β-d-Glucan in Eumycetoma Patients.

Ahmed H Fahal1, Malcolm A Finkelman2, Yonglong Zhang2, Wendy W J van de Sande3.   

Abstract

Mycetoma can be caused by bacteria (actinomycetoma) or fungi (eumycetoma). Here, we demonstrated in 45 eumycetoma patients, 30 actinomycetoma patients, and 30 healthy controls that (1→3)-β-d-glucan detection in serum cannot reliably be used to discriminate between the two types of mycetoma.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27440815      PMCID： PMC5035418          DOI： 10.1128/JCM.01478-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Observations on (1-3)-beta-D-glucan detection as a diagnostic tool in endemic mycosis caused by Histoplasma or Blastomyces.

Authors:  G Girouard; C Lachance; R Pelletier
Journal:  J Med Microbiol       Date:  2007-07       Impact factor: 2.472

2.  Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity.

Authors:  Monique A S H Mennink-Kersten; Dorien Ruegebrink; Paul E Verweij
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

3.  Cross-reactivity of Nocardia spp. in the fungal (1-3)-β-d-glucan assay performed on cerebral spinal fluid.

Authors:  Raffaella Koncan; Vincenza Favuzzi; Marco Ligozzi; Annarita Sorrentino; Giuseppe Cornaglia; Giuliana Lo Cascio
Journal:  Diagn Microbiol Infect Dis       Date:  2014-11-29       Impact factor: 2.803

Review 4.  The orthopaedic aspects of mycetoma.

Authors:  A H Fahal; S Shaheen; D H A Jones
Journal:  Bone Joint J       Date:  2014-03       Impact factor: 5.082

5.  Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.

Authors:  Annie Sulahian; Raphael Porcher; Anne Bergeron; Sophie Touratier; Emmanuel Raffoux; Jean Menotti; Francis Derouin; Patricia Ribaud
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

6.  1,3-β-D-Glucan contamination of common antimicrobials.

Authors:  B Liss; O A Cornely; D Hoffmann; V Dimitriou; H Wisplinghoff
Journal:  J Antimicrob Chemother       Date:  2015-12-13       Impact factor: 5.790

7.  Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan.

Authors:  Hagir A M Zein; Ahmed H Fahal; El Shiekh Mahgoub; Tasnam A El Hassan; Manar E Abdel-Rahman
Journal:  Trans R Soc Trop Med Hyg       Date:  2012-07-31       Impact factor: 2.184

8.  Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia.

Authors:  Florian Prüller; Jasmin Wagner; Reinhard B Raggam; Martin Hoenigl; Harald H Kessler; Martie Truschnig-Wilders; Robert Krause
Journal:  Med Mycol       Date:  2014-06-06       Impact factor: 4.076

Review 9.  Mycetoma medical therapy.

Authors:  Oliverio Welsh; Hail Mater Al-Abdely; Mario Cesar Salinas-Carmona; Ahmed Hassan Fahal
Journal:  PLoS Negl Trop Dis       Date:  2014-10-16

Review 10.  Global burden of human mycetoma: a systematic review and meta-analysis.

Authors:  Wendy W J van de Sande
Journal:  PLoS Negl Trop Dis       Date:  2013-11-07
View more
  1 in total

Review 1.  Mycetoma: Development of Diagnosis and Treatment.

Authors:  Xingpei Hao; Marcus Cognetti; Rhonda Burch-Smith; Emerald O'Sullivan Mejia; Gene Mirkin
Journal:  J Fungi (Basel)       Date:  2022-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.